JOHN E MADEWELL to Positron-Emission Tomography
This is a "connection" page, showing publications JOHN E MADEWELL has written about Positron-Emission Tomography.
Connection Strength
0.819
-
FDG PET/CT of primary bone tumors. AJR Am J Roentgenol. 2014 Jun; 202(6):W521-31.
Score: 0.249
-
Skeletal muscle metastases: a three-part study of a not-so-rare entity. Skeletal Radiol. 2012 Aug; 41(8):899-909.
Score: 0.209
-
Positron emission tomography-CT imaging in guiding musculoskeletal biopsy. Radiol Clin North Am. 2008 May; 46(3):475-86, v.
Score: 0.163
-
FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer. Oncologist. 2011; 16(8):1111-9.
Score: 0.051
-
Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer. Oncologist. 2011; 16(6):772-82.
Score: 0.050
-
Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis. Skeletal Radiol. 2010 Feb; 39(2):131-40.
Score: 0.045
-
Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. Br J Cancer. 2015 Nov 03; 113(9):1282-8.
Score: 0.017
-
A prospective study of bone tumor response assessment in metastatic breast cancer. Clin Breast Cancer. 2013 Feb; 13(1):24-30.
Score: 0.014
-
Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009 Jun; 10(6):606-14.
Score: 0.011
-
18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med. 2009 Mar; 50(3):340-7.
Score: 0.011